id	domain	url
admet-194	www.pub.iapchem.org	http://www.pub.iapchem.org/ojs/index.php/admet/index
admet-194	www.pub.iapchem.org	http://www.pub.iapchem.org/ojs/index.php/admet/index
admet-194	www.clinicaltrials.gov	https://www.clinicaltrials.gov/ct2/show/nct01931566?term=pioglitazone%2c+alzheimer&rank=1
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/record/nct01928420?term=nic5-15&rank=1
admet-194	www.clinicaltrials.gov	https://www.clinicaltrials.gov/ct2/show/nct01931566?term=pioglitazone%2c+alzheimer&rank=1
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/record/nct01928420?term=nic5-15&rank=1
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct01723670?term=chf-5074&rank=7
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct00606164?term=bryostatin1+alzheimer&rank=1
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct02221947?term=bryostatin1+alzheimer&rank=2
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct02431468?term=bryostatin-1+alzheimer&rank=3
admet-194	www.pfizer.com	http://www.pfizer.com/sites/default/files/product-pipeline/pipeline_080913_0.pdf
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct00965588?term=ub311&rank=1
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct01723670?term=chf-5074&rank=7
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct00606164?term=bryostatin-1+alzheimer&rank=1
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct00606164?term=bryostatin-1+alzheimer&rank=1
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct02221947?term=bryostatin-1+alzheimer&rank=2
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct02221947?term=bryostatin-1+alzheimer&rank=2
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct02431468?term=bryostatin-1+alzheimer&rank=3
admet-194	www.pfizer.com	http://www.pfizer.com/sites/default/files/product-pipeline/pipeline_080913_0.pdf
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct00965588?term=ub311&rank=1
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/study/nct02051608?term=gantenerumab+phase+3&rank=1
admet-194	www.alzforum.org	http://www.alzforum.org/therapeutics/ponezumab
admet-194	www.cochrane.org	http://www.cochrane.org/cd005380/dementia_there-is-no-evidence-that-mpacs-pbt1-or-pbt2-areof-benefit-in-alzheimers-dementia
admet-194	www.alzforum.org	http://www.alzforum.org/news/research-news/pbt2takes-dive-phase-2-alzheimers-trial
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/study/nct02051608?term=gantenerumab+phase+3&rank=1
admet-194	www.alzforum.org	http://www.alzforum.org/therapeutics/ponezumab
admet-194	www.cochrane.org	http://www.cochrane.org/cd005380/dementia_there-is-no-evidence-that-mpacs-pbt1-or-pbt2-are-of-benefit-in-alzheimers-dementia
admet-194	www.cochrane.org	http://www.cochrane.org/cd005380/dementia_there-is-no-evidence-that-mpacs-pbt1-or-pbt2-are-of-benefit-in-alzheimers-dementia
admet-194	www.alzforum.org	http://www.alzforum.org/news/research-news/pbt2-takes-dive-phase-2-alzheimers-trial
admet-194	www.alzforum.org	http://www.alzforum.org/news/research-news/pbt2-takes-dive-phase-2-alzheimers-trial
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct01492374?term=bms-241027&rank=1
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct01492374?term=bms-241027&rank=1
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct01608061?term=fornix+dbs&rank=4
admet-194	clinicaltrials.gov	https://clinicaltrials.gov/ct2/show/nct01608061?term=fornix+dbs&rank=4
admet-194	creativecommons.org	http://creativecommons.org/licenses/by/3.0/
admet-194	creativecommons.org	http://creativecommons.org/licenses/by/3.0